Nathaniel Wiest

@RManochakian @MayoClinic @ReemaTawfiqMD @guicorreiamd @OsamaMosalemMD @sai_vaishnavi_k @NayefHikmat23 @TayoAdeoyeMD @A_Adel90 @DinaElantably @MayoCancerCare A very well deserved award! Congratulations, Dr Manochakian!

🙏Sharing an #Honor I’m deeply #Humbled & Thankful to receive; The 2025 @MayoClinic #TeacherOfTheYear #Award. “When ONE teaches, TWO learn.” R. Heinlein I’m blessed, grateful & proud to work with THE BEST #Hematology/#Oncology #Fellows, to #Teach them, and to #Learn from them.

After 10 years in academic medicine, I've learned a few things - often by messing up or making assumptions. Here's a quick 🧵on 5 things I've learned that may be helpful for the budding academic...

Tumor immunology, simplified😅

“Dream. Dream. Dream on. How will I change the world? Dream.” - Me, about to start an experiment for a grant.

Massive database of funding opportunities for early-career researchers in any field. For each of the 396 entries (!!), we provide a description of the award, link to funder, eligibility criteria, deadline, and $ amount. Download it here: research.jhu.edu/rdt/funding-op…

New in Perspectives: Quackery - The fate of #sotorasib: a regulatory failure potentially harming patients thelancet.com/journals/lanon…

A great privilege to listen to, be inspired by, and, in a way, gain a small distillation of mentorship from @deniswirtz today at his fabulous lecture on 3D multiomic tumor maps and tissue infiltrating CARTs, hosted by @DoctorQMd at @MayoClinic.

1/Please share this thread on behalf of my physician colleague, Eunice Stallman, who is facing the nightmare of her 9mo daughter, Zoey, being diagnosed with brain cancer several weeks ago. @BlueCrossIdaho has added to their anguish by obstructing access to vital treatment.

In my 10+ years of co-survivorship, doing life with @DGlaucomflecken through 2 separate cancers, 1 SCA and fighting off his death with 10 mins of #CPR, only ONE (1) of the medical professionals we interacted with has ever asked how I was doing. Meet Roger. authors.elsevier.com/a/1giY02p-l5Vhe

Privilege to attend and present at #FLASCO with fellow #mayoclinic colleagues! Always great to attend, connect, and learn from this diverse group of people committed to improving cancer care in FL and beyond! Exciting times as new therapies, diagnostics, and frameworks evolve.

@cterminiPHD @fredhutch Congratulations, Tina! What an incredible career milestone. Very excited for you, and can’t wait to see what’s next!

I am thrilled to announce I will be joining the Clinical Research Division @fredhutch as an Assistant Professor! It is surreal to say the Termini Lab will open in Spring of 2022. Thank you to those who supported me – I look forward to joining such a vibrant scientific community!

Interesting fact learned at FLASCO residents and fellows conference: Progress is being made into targeting other immune checkpoint receptors including TIGIT that may synergize with traditional PD1/PDL1/CTLA4 mAbs with multiple clinical trials underway! #FLASCOfellows @FLASCO_ORG

Excited to meet our Genentech MSL for breast and ovarian cancer, Acacia Strachan! Critical to make progress in these important cancers. #FLASCOfellows @FLASCO_ORG

@FLASCO_ORG Excited to attend the FLASCO Fellows and Residents conference! Awesome exhibits and glad to meet MSLs and representatives sharing treatments moving care forward in FL and worldwide! #FLASCOfellows #FLASCO

@jstarklab @CantorLab @EmilySchleicher Thank you! This inspired me to apply for this as my first ever GRC. Looks incredible and hope to have opportunity to learn and network with such great speakers!

Just posted a photo @ Mayo Clinic instagram.com/p/CX4lQtxvzQi/…

@RManochakian @FrontOncology @MayoCancerCare @MayoClinic Honored to have been part of such a great paper and have a chance to explore the interplay between targeted therapy and immune checkpoint inhibition in EGFR mutant NSCLC! Grateful to work with @RManochakian @MayoCancerCare and publish with great team at @FrontOncology

🚨🔥Hot off the press; Comprehensive Review Article @FrontOncology by our team @MayoCancerCare on: “Role of #ImmunoTherapy in advanced #EGFR-Mutant Non-Small Cell #LungCancer.” Proud of @MedWiest 1st author mentee & future #HemOnc fellow @MayoClinic #LCSM frontiersin.org/article/10.338…

with the time spent with this patient. Who showed me that medicine is so much more than physiology, and that by simply being present and listening I can make an impact for the better. Thank you @DrDrAbhiKole for reminding me of this moment.

He thanked me for being there for him. I didn't know what to say. I felt unworthy to spend such a meaningful and powerful moment with him. Recently, I was accepted for heme-onc fellowship @MayoClinic in Florida. My journey on this path in many ways started, at least emotionally,

Inspired by @DrDrAbhiKole to share a story. One of my first patients in my clinical rotations was an amazingly warm and kind veteran with advanced pancreas cancer. I was learning my way, still learning how to pre-round and present cases etc. Every morning when I would walk into